Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -18 | -64 | -749 | -1 |
| Net Acquisitions | 0 | -486 | -3,401 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 0 | 0 | 43 |
| Purchase Sale Intangibles | 0 | 0 | -33 | N/A | N/A |
| Other Investing Activity | 148 | 192 | 36 | 0 | 23 |
| Investing Cash Flow | $115 | $-312 | $-3,461 | $-749 | $65 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 601 | N/A | 0 | 0 | 52 |
| Debt Repayment | -349 | -336 | -269 | -237 | -184 |
| Common Stock Issued | 2,577 | 7,172 | 0 | 15,898 | 21,794 |
| Other Financing Activity | -7 | -916 | -10 | -1,971 | -3,302 |
| Financing Cash Flow | $2,822 | $5,920 | $-279 | $13,690 | $18,360 |
| Exchange Rate Effect | -89 | 235 | 229 | 43 | -631 |
| Beginning Cash Position | 7,851 | 11,731 | 20,902 | 14,214 | 2,132 |
| End Cash Position | 1,021 | 7,851 | 11,731 | 20,902 | 14,214 |
| Net Cash Flow | $-6,742 | $-4,115 | $-9,400 | $6,645 | $12,713 |
| Free Cash Flow | |||||
| Capital Expenditure | -33 | -18 | -97 | -749 | -38 |
| Free Cash Flow | -33 | -18 | -97 | -749 | -38 |